New user? / Forgot your password?
0 Item | 0,00 €
Ensure Compliance with High-Purity Meloxicam Reference Materials
Unlock precision in residue analysis with our high-purity Meloxicam reference materials. Essential for laboratories focused on food and environmental analysis, our products meet international quality standards, ensuring accurate and reliable results. Partner with HPC Standards GmbH for unparalleled expertise in analytical standards.
Product | Catalog No./ CAS No. | Quantity | Price | |
---|---|---|---|---|
679608 | 1X10MG | Please log in. | ||
D3-Meloxicam solution | 690898 | 1X1ML | Please log in. | |
676569 | 1X100MG | Please log in. | ||
Meloxicam solution | 692327 | 1X5ML | Please log in. |
Accurate and Reliable Standards for Residue Analysis
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It is available in oral and intravenous forms and is known for its selective inhibition of cyclooxygenase-2 (COX-2) over cyclooxygenase-1 (COX-1).
Our high-purity reference materials for Meloxicam are essential for laboratories conducting food and environmental analysis to ensure compliance with regulatory limits. These products are tested according to international quality requirements and meet the highest industrial standards.
Meloxicam is primarily used to manage pain and inflammation in conditions such as osteoarthritis and rheumatic diseases. It is also used in veterinary medicine for dogs and other animals.
Meloxicam is a prescription-only medication in many regions, including the US, EU, Australia, and Canada. Regulatory guidelines often recommend using the lowest effective dose for the shortest duration to minimize adverse effects.
Regular monitoring is essential for patients on long-term Meloxicam therapy to detect potential adverse effects, especially gastrointestinal and cardiovascular issues.
Common side effects include abdominal pain, dizziness, swelling, headache, and rash. Serious side effects may include heart disease, stroke, kidney problems, and stomach ulcers. Meloxicam use is not recommended in the third trimester of pregnancy.
Meloxicam has been investigated as an alternative to diclofenac to prevent deaths of vultures. However, its environmental impact requires careful consideration, especially in veterinary applications.
Patients should inform their healthcare providers about any history of cardiovascular disease, gastrointestinal issues, or other significant health conditions before starting Meloxicam. The drug should be used with caution in patients with a higher risk of adverse effects.
Our reference materials for Meloxicam are designed to provide accurate and reliable results in residue analysis. They are essential for ensuring compliance with regulatory limits and maintaining high-quality standards in analytical laboratories.